Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints | Zendy

PoYu Liu | Zendy; ZhiYuan Shi | Zendy; KwongChung Tung | Zendy; ChingLin Shyu | Zendy; KunWei Chan | Zendy; Jai-Wen Liu | Zendy; ZongYen Wu | Zendy; Chih-Chuan Kao | Zendy; YiChing Huang | Zendy; Chin-Fu Lin | Zendy

Open Access

Antimicrobial resistance to cefotaxime and ertapenem in Enterobacteriaceae: the effects of altering clinical breakpoints

Author(s) -

PoYu Liu,

ZhiYuan Shi,

KwongChung Tung,

ChingLin Shyu,

KunWei Chan,

Jai-Wen Liu,

ZongYen Wu,

Chih-Chuan Kao,

YiChing Huang,

Chin-Fu Lin

Publication year - 2014

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.3335

Subject(s) - ertapenem , cefotaxime , klebsiella pneumoniae , microbiology and biotechnology , medicine , antibiotic resistance , carbapenem , enterobacteriaceae , antibiotics , meropenem , biology , escherichia coli , biochemistry , gene

The Clinical and Laboratory Standards Institute (CLSI) updated its antimicrobial susceptibility testing interpretation criteria for Enterobacteriaceae. This study assessed the effects of clinical breakpoint changes in the CLSI 2009 to 2012 guidelines on antibiotic susceptibility testing reports.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research